{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T11:46:58Z","timestamp":1747136818701,"version":"3.30.0"},"reference-count":14,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.3201\/eid2808.220584","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T15:24:31Z","timestamp":1658417071000},"page":"1708-1712","source":"Crossref","is-referenced-by-count":7,"title":["Effectiveness of Naturally Acquired and Vaccine-Induced Immune Responses to SARS-CoV-2 Mu Variant"],"prefix":"10.3201","volume":"28","author":[{"given":"Edmilson F.","family":"de Oliveira-Filho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bladimiro","family":"Rincon-Orozco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Jones-Cifuentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Pe\u00f1a-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"M\u00fchlemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Drosten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres","family":"Moreira-Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Felix","family":"Drexler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2808.220584-202207191243-R1","doi-asserted-by":"publisher","first-page":"105038","DOI":"10.1016\/j.meegid.2021.105038","article-title":"Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2.","volume":"95","author":"Laiton-Donato","year":"2021","journal-title":"Infect Genet Evol"},{"key":"key-10.3201\/eid2808.220584-202207191243-R2","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1056\/NEJMc2114706","article-title":"Neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine serum.","volume":"385","author":"Uriu","year":"2021","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2808.220584-202207191243-R3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1080\/22221751.2022.2027219","article-title":"Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma.","volume":"11","author":"Wang","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"key-10.3201\/eid2808.220584-202207191243-R4","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.7150\/ijbs.59184","article-title":"Construction and applications of SARS-CoV-2 pseudoviruses: a mini review.","volume":"17","author":"Chen","year":"2021","journal-title":"Int J Biol Sci"},{"key":"key-10.3201\/eid2808.220584-202207191243-R5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fimmu.2013.00081","article-title":"Variation between populations in the innate immune response to vaccine adjuvants.","volume":"4","author":"Kollmann","year":"2013","journal-title":"Front Immunol"},{"key":"key-10.3201\/eid2808.220584-202207191243-R6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1056\/NEJMc2110093","article-title":"ChAdOx1 nCoV-19 vaccine efficacy against the B.1.351 variant.","volume":"385","author":"Madhi","year":"2021","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2808.220584-202207191243-R7","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.3201\/eid2710.211427","article-title":"Breakthrough infections of SARS-CoV-2 Gamma variant in fully vaccinated gold miners, French Guiana, 2021.","volume":"27","author":"Vignier","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2808.220584-202207191243-R8","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1126\/science.abi9745","article-title":"Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.","volume":"373","author":"Cai","year":"2021","journal-title":"Science"},{"key":"key-10.3201\/eid2808.220584-202207191243-R9","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1126\/science.abn8652","article-title":"Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement.","volume":"375","author":"McCallum","year":"2022","journal-title":"Science"},{"key":"key-10.3201\/eid2808.220584-202207191243-R10","doi-asserted-by":"publisher","first-page":"2027197","DOI":"10.1080\/21645515.2022.2027197","article-title":"Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines.","volume":"18","author":"Hossain","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.3201\/eid2808.220584-202207191243-R11","doi-asserted-by":"crossref","unstructured":"Uriu K, Cardenas P, Munoz E, Barragan V, Kosugi Y, Shirakawa K,  Characterization of the immune resistance of SARS-CoV-2 Mu variant and the robust immunity induced by Mu infection. J Infect Dis. 2022:jiac053.","DOI":"10.1101\/2021.11.23.469770"},{"key":"key-10.3201\/eid2808.220584-202207191243-R12","unstructured":"Gutierrez B, Marquez S, Prado-Vivar B, Becerra-Wong M, Guadalupe JJ, Candido DDS,  Genomic epidemiology of SARS-CoV-2 transmission lineages in Ecuador. Virus Evol. 2021;7:veab051."},{"key":"key-10.3201\/eid2808.220584-202207191243-R13","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJMc2119270","article-title":"Effectiveness of BNT162b2 vaccine against Omicron variant in South Africa.","volume":"386","author":"Collie","year":"2022","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2808.220584-202207191243-R14","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/28\/8\/22-0584_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:56:36Z","timestamp":1732989396000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/28\/8\/22-0584_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2808.220584","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"type":"print","value":"1080-6040"},{"type":"electronic","value":"1080-6059"}],"subject":[],"published":{"date-parts":[[2022,8]]}}}